{
      "ptx_code": "PTX031",
      "chem_name": "Dexamethasone",
      "casrn": "50-02-2",
      "dtxsid": "DTXSID3020384",
      "smiles": "[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C",
      "inchikey": "UREBDLICKHMUKA-CXSFZGCWSA-N",
      "label": "PTX031 | Dexamethasone",
      "drugbank_id": "DB01234",
      "use_class": "Pharmaceutical",
      "tox_class": "Neurotoxicity; Ototoxicity; Hepatotoxicity; Immunotoxicity",
      "chem_name_user": "dexamethasone",
      "mw_g_mol": "392.47",
      "solubility_h2o_mol_liter": "1.05e-04",
      "source_solubility_h2o": "COMPTOX",
      "henry_coefficient_atm_m3_mol": "6.56e-11",
      "source_henry": "COMPTOX (Opera)",
      "log_kaw_kh_rt": "8.57",
      "source_kaw": "LSER eq 1",
      "pka_acid": "13.02;14.13;14.97",
      "pka_base": "",
      "source_pka": "ACD pKa/GALAS",
      "log_kow_liter_liter": "1.94",
      "source_kow": "experimental Hansch,C et al. (1995)",
      "log_dlipw_ph74_liter_liter": "1.73",
      "source_dlipw": "LSERD, eq. 1  (?mw=1)",
      "freely_dissolved_fraction": "0.71",
      "density_kg_liter": "1.32",
      "source_density": "COMPTOX",
      "average_mass": "392.47",
      "boiling_point": "",
      "source_boiling_point": "",
      "melting_point": "247.5 \u00b0C",
      "source_melting_point": "PhysPropNCCT",
      "vapor_pressure": "",
      "source_vapor_pressure": "",
      "baseline_drerio": "3220.00",
      "baseline_dmagna": "1280.00",
      "baseline_celegans": "2772.50",
      "baseline_xlaevis": "674.39",
      "baseline_dmelanogaster": "11347.91",
      "baseline_cells": "6.77e-04",
      "baseline_cells_generic_micromole_liter_free_ec10": "4.84e-04",
      "moa_drugbank": "The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]\n\nGlucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.[A187463]\n\nLower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]",
      "protein_binding": "Dexamethasone is approximately 77% protein bound in plasma.[L10710] The majority of protein binding is with serum albumin.[A188559] Dexamethasone does not significantly bind to corticosteroid binding protein.[A188559]",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 18,
                  "AOP_name": "PPAR\u03b1 activation in utero leading to impaired fertility in males "
            },
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 36,
                  "AOP_name": "Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis "
            },
            {
                  "AOP_id": 54,
                  "AOP_name": "Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment  "
            },
            {
                  "AOP_id": 57,
                  "AOP_name": "AhR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 97,
                  "AOP_name": "5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline "
            },
            {
                  "AOP_id": 98,
                  "AOP_name": "5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation "
            },
            {
                  "AOP_id": 123,
                  "AOP_name": "Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription "
            },
            {
                  "AOP_id": 131,
                  "AOP_name": "Aryl hydrocarbon receptor activation leading to uroporphyria "
            },
            {
                  "AOP_id": 148,
                  "AOP_name": "EGFR Activation Leading to Decreased Lung Function "
            },
            {
                  "AOP_id": 154,
                  "AOP_name": "Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response "
            },
            {
                  "AOP_id": 167,
                  "AOP_name": "Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse. "
            },
            {
                  "AOP_id": 187,
                  "AOP_name": "Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage "
            },
            {
                  "AOP_id": 195,
                  "AOP_name": "5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase "
            },
            {
                  "AOP_id": 200,
                  "AOP_name": "Estrogen receptor activation leading to breast cancer   "
            },
            {
                  "AOP_id": 203,
                  "AOP_name": "5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline "
            },
            {
                  "AOP_id": 204,
                  "AOP_name": "5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase "
            },
            {
                  "AOP_id": 318,
                  "AOP_name": "Glucocorticoid Receptor activation leading to hepatic steatosis "
            }
      ],
      "targets": [
            "Androgen receptor",
            "Annexin A1",
            "Aryl hydrocarbon receptor",
            "Glucocorticoid receptor",
            "Nitric oxide synthase, inducible",
            "Nuclear receptor subfamily 0 group B member 1",
            "Nuclear receptor subfamily 1 group I member 2"
      ]
}